中药联合高压氧辅助治疗对改善TACE术治疗的原发性肝癌患者不良反应的作用观察

doi:10.3969/j.issn.1672-5069.2020.05.038

Journal of Practical Hepatology ›› 2020, Vol. 23 ›› Issue (5): 755-756.doi: 10.3969/j.issn.1672-5069.2020.05.038

Previous Articles Next Articles

Application of traditional Chinese medicineand hyperbaric oxygen after TACE for treatment of patients with primary liver cancer

Liu Kewan. Liu Yuxing,Song Haiyan,et al.

Department of Hyperbaric Oxygen Treatment, 901^st Hospital, Joint Service Supporting Force of Chinese People's Liberation Army, Hefei 230031, Anhui Province, China

Online:2020-09-10 Published:2020-09-11

Abstract

Liu Kewan. Liu Yuxing,Song Haiyan,et al.. Application of traditional Chinese medicineand hyperbaric oxygen after TACE for treatment of patients with primary liver cancer[J]. Journal of Practical Hepatology, 2020, 23(5): 755-756.

[1]	Han Pengwei, Wang Huming, Zhao Tianyong. Clinical feature and prognostic factors of primary liver cancer patients with serum AFP negative after TACE [J]. Journal of Practical Hepatology, 2020, 23(5): 715-718.
[2]	Lu Bin, Cheng Min.. Serum level of dickopff 1 in patients with hepatocellular carcinoma and its impact on prognosis after TACE treatment [J]. Journal of Practical Hepatology, 2020, 23(5): 719-722.
[3]	Zhou Binbin,Sun Yaochen,Huang Haifan, et al.. Evaluation of functional magnetic resonance imaging in patients with hepatocellular carcinoma after TACE [J]. Journal of Practical Hepatology, 2020, 23(5): 723-726.
[4]	Liu Xu, Hu Yuchang, Cheng Lu, et al.. Clinicopathological manifestation of primary liver adenosquamous carcinoma: An analysis of six cases [J]. Journal of Practical Hepatology, 2020, 23(5): 727-730.
[5]	Zhang Jing, Zhou Xinmin. Administration of recombinant human thrombopoietin before operation in patients with liver cirrhosis and hepatocellular carcinoma and thrombocytopenia [J]. Journal of Practical Hepatology, 2020, 23(4): 552-555.
[6]	Meng Haisheng, Hu Dongmei, Wang Haitao, et al. Application of ultrasound single mode fusion imaging in the immediate evaluation of microwave ablation in treatment of patients with primary liver cancer [J]. Journal of Practical Hepatology, 2020, 23(4): 572-575.
[7]	Gu Shiyu, Qin Wenju, Gao Jianzhi, et al. Poor prognosis of patients withhepatocellular carcinoma after hepatectomy with high cancerous tissue Hic-5 and COL1A1 expression [J]. Journal of Practical Hepatology, 2020, 23(4): 576-580.
[8]	Quan Yaning, Shang Xiaojie, Meng Xuan, et al. Application of microwave ablation in treatment of patients with small primary liver cancer under real-time contrast-enhanced ultrasound and fusion image navigation guidance [J]. Journal of Practical Hepatology, 2020, 23(4): 581-584.
[9]	Li Xingyan, Liu Gang, Li Shiyou, et al. Ultrasoundmanifestation of hepatic distomiasis and its clinical outcomes: An analysis of 30 cases [J]. Journal of Practical Hepatology, 2020, 23(4): 597-600.
[10]	Shen Jingyong, Guo Xiangyun, Zhou Hui, et al. Effect of radical therapy forHelicobacter pylori on serum inflammatory factors and lipid metabolism in patients with Hp positive non-alcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2020, 23(3): 364-367.
[11]	Wu Jie, Xie Lixiang, Xiu Jin. The value of US, CT and MRI in the evaluation of tumor activity in patients with primary liver cancer after TACE intervention [J]. Journal of Practical Hepatology, 2020, 23(3): 419-422.
[12]	Xu Xueqing, Li Bingchao,Feng Kaili. Clinical value of enhanced CT texture analysis technique in predicting short- term recurrence of liver tumor in patients with HCC after TACE [J]. Journal of Practical Hepatology, 2020, 23(3): 423-426.
[13]	Zhou Cuimei, Hu Lifen, Li Jiabin, et al. Application of mind map in the management of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2020, 23(2): 187-190.
[14]	Wang Wei, Du Xiaofei, Lu Yunjian. Predicting value for survival by preoperative NLR of patients with massive hepatocellular carcinoma treated by TACE combined with MWA [J]. Journal of Practical Hepatology, 2020, 23(2): 260-263.
[15]	Li Tianzong, Zhou Song, Zhou Shi. Significance of blood miR-145 in patients with hepatocellular carcinoma after TACE treatment [J]. Journal of Practical Hepatology, 2020, 23(2): 264-267.

Application of traditional Chinese medicineand hyperbaric oxygen after TACE for treatment of patients with primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments